Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a 9.865\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a) CN(C(=S)NCCN1CCOCC1)C(c1ccccc1)c1ccccc1
b) Cc1ccc(CONC(=O)c2ccc([N+](=O)[O-])cc2)cc1
c) CCCCCC(=O)NC(=S)Nc1ccc(N2CCCCC2)c(Cl)c1
d) CCC(C)(C)n1nnnc1C(c1cccnc1)N1CCCC(C)C1
Answer: d. CCC(C)(C)n1nnnc1C(c1cccnc1)N1CCCC(C)C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)(C)n1nnnc1C(c1cccnc1)N1CCCC(C)C1
CCC(C)(C)n1nnnc1C(c1cccnc1)N1CCCC(C)C1
3-[[1-(2-methylbutan-2-yl)tetrazol-5-yl]-(3-methylpiperidin-1-yl)methyl]pyridine